Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00836238 · ClinicalTrials.gov registry record
Questionnaire and Fall Risk Assessment
A clinical trial of Prostate Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT00836238: Completed study of Prostate Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00836238 is a study of Prostate Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 34 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00836238, a study of Prostate Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn if your answers to questions during an interview can help researchers predict how well you function physically and if you are at a high risk for falls. Primary Objectives: -To determine how accurately a simple questionnaire can predict three objective measures of function in elderly patients with prostate cancer. Secondary Objectives: * To assess the correlations between three functional tests and the number of self-reported falls in elderly patients with prostate cancer. * To determine risk factors related to number of falls in elderly prostate cancer patients.
Conditions Studied
Interventions
- BEHAVIORAL Interview
- OTHER Physical Function Tests
Study Locations (1)
Texas
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00836238
The ClinicalTrials.gov registry entry for NCT00836238 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (94% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Interview is the first listed.
NCT00836238 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00836238 about?
NCT00836238 is a clinical study titled "Questionnaire and Fall Risk Assessment". The goal of this research study is to learn if your answers to questions during an interview can help researchers predict how well you function physically and if you are at a high risk for falls. Primary Objectives: -To determine how accurately a simple questionnaire can predict three objective me...
What is the current status of trial NCT00836238?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2009-02. Estimated completion is 2009-06.
What conditions does trial NCT00836238 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00836238?
The interventions under investigation include: Interview (BEHAVIORAL), Physical Function Tests (OTHER).
Who is sponsoring clinical trial NCT00836238?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00836238 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.